The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment

Nature Reviews. Drug Discovery
Randy Johnson, Georg Halder

Abstract

The Hippo signalling pathway is an emerging growth control and tumour suppressor pathway that regulates cell proliferation and stem cell functions. Defects in Hippo signalling and hyperactivation of its downstream effectors Yes-associated protein (YAP) and transcriptional co-activator with PDZ-binding motif (TAZ) contribute to the development of cancer, which suggests that pharmacological inhibition of YAP and TAZ activity may be an effective anticancer strategy. Conversely, YAP and TAZ can also have beneficial roles in stimulating tissue repair and regeneration following injury, so their activation may be therapeutically useful in these contexts. A complex network of intracellular and extracellular signalling pathways that modulate YAP and TAZ activities have recently been identified. Here, we review the regulation of the Hippo signalling pathway, its functions in normal homeostasis and disease, and recent progress in the identification of small-molecule pathway modulators.

References

Sep 15, 1995·The Journal of Biological Chemistry·C L Creasy, J Chernoff
Sep 17, 1996·Proceedings of the National Academy of Sciences of the United States of America·L K TaylorR L Erikson
Mar 30, 2001·The Journal of Biological Chemistry·S StranoG Blandino
Jul 18, 2002·Nature Reviews. Drug Discovery·Margaret A Somerville
Nov 8, 2002·Development·Madhuri Kango-SinghGeorg Halder
Sep 23, 2003·Nature Cell Biology·Ryan S UdanGeorg Halder
Sep 23, 2003·Nature Cell Biology·Sophie PantalacciPierre Léopold
Feb 3, 2005·Oncogene·Eunice H Y ChanHerman H W Silljé
Mar 5, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yuri TakahashiShinzaburo Noguchi
Sep 6, 2005·Cancer Research·Corisande BaldwinWan L Lam
Dec 8, 2005·Proceedings of the National Academy of Sciences of the United States of America·Masao MurakamiOsamu Nakagawa
Aug 9, 2006·Proceedings of the National Academy of Sciences of the United States of America·Michael OverholtzerDaniel A Haber
Sep 19, 2006·Nature Genetics·Eunjoo ChoKenneth D Irvine
Sep 26, 2006·Current Biology : CB·Maria WilleckeGeorg Halder
Oct 19, 2006·Current Biology : CB·F Christian Bennett, Kieran F Harvey
Nov 23, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Piergiorgio ModenaGabriella Sozzi
Dec 19, 2006·Current Biology : CB·Cedric PoleselloNicolas Tapon
Jun 1, 2007·Molecular Carcinogenesis·Claudia SeidelReinhard Dammann
Oct 18, 2007·Brain : a Journal of Neurology·C O Hanemann
Nov 6, 2007·Current Biology : CB·Fernando D CamargoThijn R Brummelkamp
Dec 26, 2007·The Journal of Biological Chemistry·Yawei HaoXiaolong Yang
Jan 30, 2008·Molecular and Cellular Biology·Qun-Ying LeiKun-Liang Guan

❮ Previous
Next ❯

Citations

Jun 4, 2014·Fibrogenesis & Tissue Repair·Thomas Volckaert, Stijn De Langhe
Jul 23, 2014·Nature Communications·Alessandra LuchiniLance A Liotta
Feb 26, 2016·Frontiers in Physiology·Martina FischerCatherine Coirault
Jul 29, 2015·The Journal of Cell Biology·Nam-Gyun Kim, Barry M Gumbiner
Jan 30, 2016·Nature Reviews. Drug Discovery·Fabrizio MarcucciRuggero De Maria
Dec 4, 2014·Journal of Drug Targeting·Delin KongChun-Bo Teng
Aug 20, 2015·Journal of Medicinal Chemistry·Dennis Schade, Alleyn T Plowright
Sep 2, 2015·Proceedings of the National Academy of Sciences of the United States of America·Ieva GailiteNicolas Tapon
Nov 5, 2015·The New England Journal of Medicine·W Marston LinehanUNKNOWN Cancer Genome Atlas Research Network
Sep 12, 2015·Journal of Neuropathology and Experimental Neurology·Ji-Eun OhHiroko Ohgaki
Jul 30, 2016·Oncoimmunology·Simonetta BuglioniMarcello Maugeri-Saccà
Sep 22, 2015·Frontiers in Medicine·Bram PiersmaMiriam Boersema
Sep 22, 2015·Frontiers in Oncology·Michael D DeelCorinne M Linardic
May 30, 2015·Cell Death and Differentiation·F Di CaraK King-Jones
Apr 2, 2015·Annals of the American Thoracic Society·Peter B Bitterman
Mar 31, 2015·Nature Cell Biology·Iswar K Hariharan
Mar 10, 2015·Nature Cell Biology·Jung-Soon MoKun-Liang Guan
Jul 30, 2014·Frontiers in Physiology·Stefania PagliariGiancarlo Forte
Oct 9, 2014·Annual Review of Physiology·Fa-Xing YuKun-Liang Guan
Jun 21, 2016·Genes·Emma FallahiDavid Matallanas
Jul 6, 2016·Nature Chemical Biology·Baoen ChenXu Wu
Mar 8, 2016·Cell Reports·Fengju ChenChad J Creighton
Aug 25, 2016·Scientific Reports·Sepideh VahidAmina Zoubeidi
Apr 28, 2016·American Journal of Respiratory and Critical Care Medicine·Tatiana V KudryashovaElena A Goncharova
Nov 3, 2016·Open Biology·Shu-Ping Wang, Lan-Hsin Wang
Feb 2, 2017·Nature Communications·Chunxiao LiGuangwei Liu
Mar 21, 2017·ELife·Mohammad Hossein RohbanAnne E Carpenter
Dec 18, 2016·Journal of Cellular Physiology·Anna Di BenedettoMarcello Maugeri-Saccà

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Related Papers

Genes & Development
Fa-Xing Yu, Kun-Liang Guan
Journal of Genetics and Genomics = Yi Chuan Xue Bao
Mengxin Yin, Lei Zhang
Nature Reviews. Cancer
Kieran F HarveyDavid M Thomas
Seminars in Cell & Developmental Biology
Molly C Schroeder, Georg Halder
© 2021 Meta ULC. All rights reserved